Alphatec Announces Sales Leadership Appointment And Successful Closing of Expanded Credit Facility With Squadron Capital
New Sales Leadership
Sponsel joined ATEC in
Sponsel brings 13 years of spine sales and leadership experience to the EVP, Sales position. He began his spine career with
“Dave’s astute executive leadership has already contributed significantly to the transformation of the ATEC distribution channel,” said
Miles continued, “I would also like to thank Jeff for his support as Interim Head of Sales during a critical transitional time for ATEC. His leadership over the past few months has been invaluable, and I know he will continue to provide vital influence both as a consultant and as a Board member.”
Closing of Credit Facility
In connection with the additional financing commitment, ATEC will issue a warrant to Squadron to purchase 4.8 million shares of ATEC common stock at an exercise price of
“We are pleased to be expanding our partnership with Squadron,” said
About Alphatec Holdings, Inc.
Additional information can be found at www.atecspine.com.
This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainty. Such statements are based on management's current expectations and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. The Company cautions investors that there can be no assurance that actual results or business conditions will not differ materially from those projected or suggested in such forward-looking statements as a result of various factors. Forward-looking statements include the references to the Company’s strategy in significantly repositioning the ATEC brand and its sales and distribution channels, its future ability to finance its operations, and turning the Company into a growth organization. The important factors that could cause actual operating results to differ significantly from those expressed or implied by such forward-looking statements include, but are not limited to: the uncertainty of success in developing new products or products currently in the Company’s pipeline; the uncertainties in the Company’s ability to execute upon its strategic operating plan; the uncertainties regarding the ability to successfully license or acquire new products, and the commercial success of such products; failure to achieve acceptance of the Company’s products by the surgeon community; failure to obtain
Chief Financial Officer
Source: Alphatec Holdings, Inc.